- Rapidly growing cannabis market evolving to include diverse clientele seeking unique strains
- PACR uses genetics-first approach to cultivate exclusive high-yield strains with varying cannabinoid profiles
- PACR catalog features 350 tested cultivars, including 50 super-elite strains prized for unique properties
Smoking marijuana decades ago traditionally meant rolling one type of cannabis that was grown outdoors under mostly natural conditions. Decades later, the market has completely transformed to accommodate the needs of savvy consumers who understand different strains and their varying effects.
PacRoots Cannabis (CSE: PACR) (OTCQB: PACRF), a Canada-based cannabis company dedicated to producing premium-quality strains and products through a genetics-focused approach, is positioned to benefit from this market shift with roughly 350 tested cultivars in its extensive catalog, which includes 50 super-elite strains prized throughout the industry for their unique therapeutic properties.
Marijuana strains are typically differentiated by their color, smell, taste and cannabinoid profile – the latter being the phytochemical composition specific to the plant. Specialized cultivation and strain development is undertaken by many growers seeking to leverage specific properties of the plant in order to produce specialized strains for specific markets—markets which include both medical and recreational users.
The result of this innovation in cannabis cultivation has been a boom in branded cannabis strains, evidenced by increased brand recognition among loyal, repeat customers at legal dispensaries (
https://ibn.fm/iq8Ca). PACR is positioned to benefit from these emerging markets by providing retailers with high-quality strains tailored for specific uses. The company’s genetics-based approach to cultivation has produced prized strains with varying amounts of tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”) – two of over 140 known cannabinoids in the cannabis plant that can produce different effects on the body. Along with altering the cannabinoid profile of its strains, the company also leverages genetic technology to develop plants that thrive in different climatic conditions for maximum yields each season.
PACR has a competitive advantage in the industry through its strategic licensing agreement with Phenome One Corp, a privately-held full-service genetics cannabis company that gives PACR access to one of the largest living genetic cannabis libraries in Canada. This valuable, unparalleled resource has enabled the Company to diversify its product catalog to include hundreds of cultivars and dozens of elite strains offering specialized beneficial characteristics unique to the market.
The cannabis market has evolved from small-time dealers on street corners to an entire industry with differentiated products and discerning, knowledgeable consumers. PACR is leveraging this market shift through a genetic-first approach to cultivation that produces first-in-class high-yield strains which appeal to a wide variety of consumers across the rapidly growing legal cannabis market.
For more information, visit the company’s website at
www.PacRoots.ca.
NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at
http://ibn.fm/PACR
